Investors finally get a glimpse of Evolent Health Inc (EVH) volume hitting the figure of 5.11 million.

On Friday, Evolent Health Inc (NYSE: EVH) opened lower -4.69% from the last session, before settling in for the closing price of $20.06. Price fluctuations for EVH have ranged from $19.74 to $35.00 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Annual sales at Healthcare sector company grew by 27.32% over the past five years. Company’s average yearly earnings per share was noted 40.12% at the time writing. With a float of $110.62 million, this company’s outstanding shares have now reached $113.89 million.

Let’s look at the performance matrix of the company that is accounted for 4700 employees.

Evolent Health Inc (EVH) Insider and Institutional Ownership

A key investor’s attitude towards the stock of the Health Information Services industry is another important factor to consider. The insider ownership of Evolent Health Inc is 4.81%, while institutional ownership is 110.97%. The most recent insider transaction that took place on Dec 05 ’23, was worth 3,741,475. In this transaction Chief Executive Officer of this company sold 141,000 shares at a rate of $26.54, taking the stock ownership to the 637,645 shares. Before that another transaction happened on Nov 15 ’23, when Company’s PRESIDENT sold 11,000 for $30.00, making the entire transaction worth $330,000. This insider now owns 198,333 shares in total.

Evolent Health Inc (EVH) Latest Financial update

According to the Wall Street analysts, stocks earnings will be around 40.12% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.00% during the next five years compared to -13.43% drop over the previous five years of trading.

Evolent Health Inc (NYSE: EVH) Trading Performance Indicators

Check out the current performance indicators for Evolent Health Inc (EVH). In the past quarter, the stock posted a quick ratio of 1.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.02. Likewise, its price to free cash flow for the trailing twelve months is 17.04.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.25, a number that is poised to hit 0.24 in the next quarter and is forecasted to reach 1.58 in one year’s time.

Technical Analysis of Evolent Health Inc (EVH)

Evolent Health Inc (NYSE: EVH) saw its 5-day average volume 2.51 million, a positive change from its year-to-date volume of 1.19 million. As of the previous 9 days, the stock’s Stochastic %D was 11.60%. Additionally, its Average True Range was 0.95.

During the past 100 days, Evolent Health Inc’s (EVH) raw stochastic average was set at 1.61%, which indicates a significant decrease from 4.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.32% in the past 14 days, which was lower than the 40.78% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $24.27, while its 200-day Moving Average is $28.42. Nevertheless, the first resistance level for the watch stands at $19.96 in the near term. At $20.80, the stock is likely to face the second major resistance level. The third major resistance level sits at $21.35. If the price goes on to break the first support level at $18.57, it is likely to go to the next support level at $18.02. The third support level lies at $17.18 if the price breaches the second support level.

Evolent Health Inc (NYSE: EVH) Key Stats

There are currently 116,213K shares outstanding in the company with a market cap of 2.22 billion. Presently, the company’s annual sales total 1,964 M according to its annual income of -113,040 K. Last quarter, the company’s sales amounted to 639,650 K and its income totaled -17,280 K.